ASX · CSL.AX
CSL Limited
A$200.73+A$3.23 (+1.64%)
CSL Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
Loading market information…
ASX · BLS.AX · AUD
Stock price
Quote as of Oct 30, 2026, 05:10 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
BLS Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 21.15% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:17 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
A$200.73+A$3.23 (+1.64%)
CSL Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
A$2.54+A$0.04 (+1.6%)
Mayne Pharma Group Limited’s quoted price sits in the lower half of its reported 52-week range, 57.95% below the high.
A$2.74A$0.00 (0.0%)
Vita Life Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 5.52% below the high.
A$0.36A$0.00 (0.0%)
Biome Australia Limited’s quoted price sits in the upper half of its reported 52-week range, 26.53% below the high.
A$0.14A$0.00 (0.0%)
Star Combo Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 49.09% below the high.
A$0.06+A$0.00 (+7.14%)
Little Green Pharma Ltd’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
A$0.01A$0.00 (0.0%)
ECS Botanics Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.5% below the high.
A$0.07A$0.00 (0.0%)
Wellnex Life Limited’s quoted price sits in the lower half of its reported 52-week range, 68.57% below the high.
